- Catalent, Inc. to Present at the Stephens Annual Investment Conference
- Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline
- Catalent, Inc. Reports First Quarter Fiscal 2023 Results
- Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast
- Catalent, Inc. to Present at September Investor Conferences
As of last trade,
Catalent Inc (CTLT:NYQ) traded at 50.48, 24.06% above the 52 week low of 40.69 set on Nov 22, 2022.
40.69Nov 22 2022130.97Dec 16 2021
Markit short selling activity
|Market cap||9.40bn USD|
|EPS (TTM)||2.34 |
Data delayed at least 15 minutes, as of Dec 05 2022 19:24 GMT.